tiprankstipranks
Zentalis Pharmaceuticals (ZNTL)
NASDAQ:ZNTL
US Market
Holding ZNTL?
Track your performance easily

Zentalis Pharmaceuticals (ZNTL) Financial Statements

287 Followers

Zentalis Pharmaceuticals Financial Overview

Zentalis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.526; its P/E ratio is ―; Zentalis Pharmaceuticals is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 40.56M--
Gross Profit--$ 40.56M$ 900.00K-
EBIT$ -40.19M$ -88.01M$ -24.77M$ -67.92M$ -62.72M
EBITDA$ -39.86M$ -84.92M$ -24.44M$ -67.58M$ -62.37M
Net Income Common Stockholders$ -40.16M$ -88.28M$ 10.07M$ -60.92M$ -55.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 41.32M$ 36.98M$ 37.62M$ 482.92M$ 516.64M
Total Assets$ 450.66M$ 491.68M$ 557.48M$ 551.69M$ 585.72M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 96.33M$ 109.10M$ 98.71M$ 114.30M$ 103.82M
Stockholders Equity$ 354.33M$ 382.58M$ 458.77M$ 437.28M$ 481.77M
Cash Flow-
Free Cash Flow$ -44.05M$ -35.26M$ -52.01M$ -40.77M$ -38.76M
Operating Cash Flow$ -44.05M$ -35.14M$ -51.97M$ -40.60M$ -38.66M
Investing Cash Flow$ 48.24M$ 34.49M$ 61.55M$ -42.06M$ -117.45M
Financing Cash Flow$ 92.00K$ 9.00K$ 7.00K-$ 309.00K
Currency in USD

Zentalis Pharmaceuticals Earnings and Revenue History

Zentalis Pharmaceuticals Debt to Assets

Zentalis Pharmaceuticals Cash Flow

Zentalis Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis